- #1
McGyver
The commissioner of the Food & Drug Administration for the last three years, Lester Crawford, resigned today amidst sinking morale and criticisms from Congress, MSN reports:
http://www.msnbc.msn.com/id/9455426/
At the center of Crawford's resignation, were unusual steps he took to block the approval and sale of new women's contraceptives - angering the head of that division to resign.
I have not followed the FDA's internal contraceptive issue roughings that closely, but I suspect (Crawford) as a Bush appointee, could have allowed religious beliefs to interfere with the agency's primary responsibility of "public safety," and if so - that is unacceptable. Any of you with more information on this contraceptive issue - please share.
Crawford also took heat for drug safety issues revealed one year ago relating to the arthritis treatment drug, "Vioxx," and the class of "Cox-2 inhibitor" drugs. It remains unclear what role, or accepting of blame, Crawford played with any of these drugs. It was one of the FDA's leading scientist, David Graham, who leveled serious criticisms of the FDA's approval and safety record with a number of leading U.S. drugs. Vioxx related litigation is now underway, with a second trial due to get underway in New Jersey.
As a final thorn, the FDA and Crawford also took heat for not being more proactive and tougher on drug manufacturers for some of their television and print advertisements. It was only in 1996, that prescription drug and device manufacturers were, by passage of special legislation from Congress, permitted to market/advertise directly to consumers. Clearly, this direct to consumer relationship by drug and device manufacturers is still evolving - hopefully for the better.
By: Stephen Dolle
Dolle Communications
www.diaceph.com
http://www.msnbc.msn.com/id/9455426/
At the center of Crawford's resignation, were unusual steps he took to block the approval and sale of new women's contraceptives - angering the head of that division to resign.
I have not followed the FDA's internal contraceptive issue roughings that closely, but I suspect (Crawford) as a Bush appointee, could have allowed religious beliefs to interfere with the agency's primary responsibility of "public safety," and if so - that is unacceptable. Any of you with more information on this contraceptive issue - please share.
Crawford also took heat for drug safety issues revealed one year ago relating to the arthritis treatment drug, "Vioxx," and the class of "Cox-2 inhibitor" drugs. It remains unclear what role, or accepting of blame, Crawford played with any of these drugs. It was one of the FDA's leading scientist, David Graham, who leveled serious criticisms of the FDA's approval and safety record with a number of leading U.S. drugs. Vioxx related litigation is now underway, with a second trial due to get underway in New Jersey.
As a final thorn, the FDA and Crawford also took heat for not being more proactive and tougher on drug manufacturers for some of their television and print advertisements. It was only in 1996, that prescription drug and device manufacturers were, by passage of special legislation from Congress, permitted to market/advertise directly to consumers. Clearly, this direct to consumer relationship by drug and device manufacturers is still evolving - hopefully for the better.
By: Stephen Dolle
Dolle Communications
www.diaceph.com